{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:39:30Z","timestamp":1792492770011,"version":"4.5.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.msard.2026.108001","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:40:40Z","timestamp":1792132840000},"page":"108001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Steroid-modified lymphoma and the Marburg variant of multiple sclerosis: tissue, time and treatment response. Reply to Hanazono et al."],"prefix":"10.1016","volume":"116","author":[{"given":"Ma\u0161an","family":"Sredanovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Krbot Skori\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3360-1748","authenticated-orcid":false,"given":"Mario","family":"Habek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.108001_bib0001","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jnnp.60.1.102","article-title":"Sentinel lesions of primary CNS lymphoma","volume":"60","author":"Alderson","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.108001_bib0002","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1017\/S0317167100015742","article-title":"Demyelination after primary central nervous system lymphoma; reversed \"sentinel\"","volume":"39","author":"Barun","year":"2012","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.108001_bib0003","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1007\/s10072-023-06919-1","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease preceding primary central nervous system lymphoma: causality or coincidence?","volume":"44","author":"Cai","year":"2023","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2026.108001_bib0004","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/bjh.17357","article-title":"MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study","volume":"193","author":"Ferreri","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.msard.2026.108001_bib0005","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jocn.2007.12.004","article-title":"Is there sentinel demyelination before development of primary CNS lymphoma?","volume":"15","author":"Habek","year":"2008","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.msard.2026.108001_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2026.107889","article-title":"Risk of misclassifying steroid-modified lymphoma under the proposed management algorithm for Marburg variant of multiple sclerosis","volume":"115","author":"Hanazono","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.108001_bib0007","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12883-016-0596-1","article-title":"Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination","volume":"16","author":"Kvarta","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2026.108001_bib0008","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jocn.2006.05.003","article-title":"Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma","volume":"14","author":"Ng","year":"2007","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.msard.2026.108001_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106908","article-title":"Towards practical management of the Marburg variant of multiple sclerosis","volume":"106","author":"Sredanovi\u0107","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.108001_bib0010","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1227\/neu.0000000000002944","article-title":"Preoperative corticosteroids reduce diagnostic accuracy of stereotactic biopsies in primary central nervous system lymphoma: a systematic review and meta-analysis","volume":"95","author":"Tosefsky","year":"2024","journal-title":"Neurosurgery"},{"key":"10.1016\/j.msard.2026.108001_bib0011","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1016\/S2352-3026(26)00098-0","article-title":"Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study","volume":"13","author":"van Rooij","year":"2026","journal-title":"Lancet Haematol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826010369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826010369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:52:49Z","timestamp":1792489969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826010369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":11,"alternative-id":["S2211034826010369"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.108001","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steroid-modified lymphoma and the Marburg variant of multiple sclerosis: tissue, time and treatment response. Reply to Hanazono et al.","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.108001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108001"}}